162 related articles for article (PubMed ID: 25337290)
1. Indolent T-lymphblastic proliferation: report of a case involving the upper aerodigestive tract.
Yang F; Liu T; Zhao H; Hu Z; Xiao L; Liu Y; Wang X; Li Z
Int J Clin Exp Pathol; 2014; 7(9):6350-6. PubMed ID: 25337290
[TBL] [Abstract][Full Text] [Related]
2. Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
Ohgami RS; Arber DA; Zehnder JL; Natkunam Y; Warnke RA
Adv Anat Pathol; 2013 May; 20(3):137-40. PubMed ID: 23574769
[TBL] [Abstract][Full Text] [Related]
3. Indolent T-lymphoblastic proliferation: report of a case with a 16-year course without cytotoxic therapy.
Velankar MM; Nathwani BN; Schlutz MJ; Bain LA; Arber DA; Slovak ML; Weiss LM
Am J Surg Pathol; 1999 Aug; 23(8):977-81. PubMed ID: 10435569
[TBL] [Abstract][Full Text] [Related]
4. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric features of incidental indolent T lymphoblastic proliferations.
Fromm JR; Edlefsen KL; Cherian S; Wood BL; Soma L; Wu D
Cytometry B Clin Cytom; 2020 May; 98(3):282-287. PubMed ID: 31571375
[TBL] [Abstract][Full Text] [Related]
6. Indolent T-lymphoblastic proliferation: report of a case with an 11-year history and association with myasthenia gravis.
Strauchen JA
Am J Surg Pathol; 2001 Mar; 25(3):411-5. PubMed ID: 11224614
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma with immature T-cell (T-lymphoblastic) proliferation.
Eun S; Jeon YK; Jang JJ
J Korean Med Sci; 2010 Feb; 25(2):309-12. PubMed ID: 20119589
[TBL] [Abstract][Full Text] [Related]
8. Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review.
Yasuda H; Tsutsui M; Ota Y; Tanaka M; Komatsu N
Histopathology; 2018 Apr; 72(5):862-866. PubMed ID: 29143359
[TBL] [Abstract][Full Text] [Related]
9. T-cell lymphoblastic leukemia/lymphoma with t(7;14)(p15;q32) [TCRγ-TCL1A translocation]: a case report and a review of the literature.
Sugimoto KJ; Shimada A; Wakabayashi M; Sekiguchi Y; Izumi H; Ota Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(5):2615-23. PubMed ID: 24966976
[TBL] [Abstract][Full Text] [Related]
10. Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease.
Kansal R; Nathwani BN; Yiakoumis X; Moschogiannis M; Sachanas S; Stefanaki K; Pangalis GA
Hum Pathol; 2015 Jul; 46(7):1057-61. PubMed ID: 25953658
[TBL] [Abstract][Full Text] [Related]
11. Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report.
Han W; Wang B; Yong X; Zhang Y; Shao M; Wang C
Pathol Oncol Res; 2023; 29():1611151. PubMed ID: 37252318
[No Abstract] [Full Text] [Related]
12. Follicular Dendritic Cell Sarcoma With Indolent T-Lymphoblastic Proliferation Is Associated With Paraneoplastic Autoimmune Multiorgan Syndrome.
Walters M; Pittelkow MR; Hasserjian RP; Harris NL; Macon WR; Kurtin PJ; Rech KLG
Am J Surg Pathol; 2018 Dec; 42(12):1647-1652. PubMed ID: 30222603
[TBL] [Abstract][Full Text] [Related]
13. CD123 Immunohistochemical Expression Is a Specific But Insensitive Marker of Early T-precursor Leukemia.
Hellman C; Marcogliese AN; Djokic M; Roth CG
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):e4-5. PubMed ID: 25906118
[No Abstract] [Full Text] [Related]
14. Indolent T-lymphoblastic proliferation: a report of three cases.
Yuanyuan Z; Jianlan X; Yanlin Z; Xiaoge Z
Virchows Arch; 2022 May; 480(5):1121-1126. PubMed ID: 34482472
[TBL] [Abstract][Full Text] [Related]
15. Unusual presentation of primary T-cell lymphoblastic lymphoma: description of two cases.
Ambrosio MR; Onorati M; Rocca BJ; Ginori A; Lobello G; Petracco G; Videtta AD; Di Nuovo F; Santopietro R; Lazzi S
Diagn Pathol; 2014 Jun; 9():124. PubMed ID: 24950962
[TBL] [Abstract][Full Text] [Related]
16. Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma-presentation in novel settings and comprehensive review of literature.
Ghezavati A; Liang CA; Mais D; Nazarullah A
J Hematop; 2023 Sep; 16(3):167-175. PubMed ID: 38175402
[TBL] [Abstract][Full Text] [Related]
17. Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression.
Ohgami RS; Sendamarai AK; Atwater SK; Liedtke M; Fleming MD; Natkunam Y; Warnke RA
Am J Surg Pathol; 2014 Sep; 38(9):1298-304. PubMed ID: 24618611
[TBL] [Abstract][Full Text] [Related]
18. Composite primary breast diffuse large B-cell lymphoma and T lymphoblastic leukemia/lymphoma: report of a case and review of literature.
Guan C; Li J; Xu P; Ouyang J; Chen B
Int J Clin Exp Pathol; 2015; 8(8):9629-37. PubMed ID: 26464729
[TBL] [Abstract][Full Text] [Related]
19. Concurrent thymoma, thymic carcinoma, and T lymphoblastic leukemia/lymphoma in an anterior mediastinal mass.
Ito J; Yoshida A; Maeshima AM; Nakagawa K; Watanabe S; Kobayashi Y; Fukuhara S; Tsuta K
Pathol Res Pract; 2015 Sep; 211(9):693-6. PubMed ID: 26150396
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic CD3 Positivity as the Only Clue for the Diagnosis of T-Acute Lymphoblastic Leukemia With Cutaneous Deposits: A Case Report.
Elbendary A; Abdelkader HA; Abdel-Galeil Y; El-Mofty M; Sultan AM; Elkomi AS; Abdel-Halim MRE
Am J Dermatopathol; 2020 Jan; 42(1):43-45. PubMed ID: 31124883
[No Abstract] [Full Text] [Related]
[Next] [New Search]
